Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Health Aff (Millwood). 2013 Jul;32(7):1251-7. doi: 10.1377/hlthaff.2012.0902.
Value-based insurance design (VBID) is an approach that attempts to improve the quality of care by selectively encouraging or discouraging the use of specific health care services, based on their potential benefit to patients' health, relative to their cost. Lowering beneficiary cost sharing or out-of-pocket spending to increase medication adherence is one common element of value-based insurance design. We conducted a systematic review of the peer-reviewed literature to evaluate the evidence of the effects of VBID policies on medication adherence and medical expenditures. We identified thirteen studies assessing the effects of VBID programs and found that the programs were consistently associated with improved adherence (average change of 3.0 percent over one year), as well as with lower out-of-pocket spending for drugs. In the studies we reviewed, providing more generous coverage did not lead to significant changes in overall medical spending for patients and insurers. Further research is needed to understand how best to structure VBID programs to both improve quality and reduce spending.
基于价值的保险设计(VBID)是一种尝试通过有选择性地鼓励或劝阻特定医疗保健服务的使用,来提高医疗服务质量的方法,这取决于这些服务对患者健康的潜在益处与其成本的相对关系。降低受益人的自付费用或自付支出以提高药物依从性是基于价值的保险设计的一个常见要素。我们对同行评议文献进行了系统回顾,以评估 VBID 政策对药物依从性和医疗支出影响的证据。我们确定了 13 项评估 VBID 计划效果的研究,发现这些计划始终与改善依从性(一年内平均变化 3.0%)以及降低药物自付支出相关。在我们审查的研究中,提供更慷慨的覆盖范围并没有导致患者和保险公司的总体医疗支出发生重大变化。需要进一步研究以了解如何最好地构建 VBID 计划,以提高质量和降低支出。